Jlang, I have not seen a comprehensive evaluati
Post# of 148177
(Total Views: 450)
Posted On: 02/26/2021 7:08:10 AM
Jlang,
I have not seen a comprehensive evaluation of cardiac dysfunction after mild Covid, though I suspect it is more prevalent than expected or desired.
I imagine you have seen this, but found it shocking nonetheless. Structural damage found in 54% of severe Covid patients after discharge. Granted, these had elevated troponin and were severe patients in hospitals.
https://www.webmd.com/lung/news/20210219/hear...with-covid
Nonetheless, this strongly supports the use of leronlimab, as inflammation has persistent consequences.
I have not seen a comprehensive evaluation of cardiac dysfunction after mild Covid, though I suspect it is more prevalent than expected or desired.
I imagine you have seen this, but found it shocking nonetheless. Structural damage found in 54% of severe Covid patients after discharge. Granted, these had elevated troponin and were severe patients in hospitals.
https://www.webmd.com/lung/news/20210219/hear...with-covid
Nonetheless, this strongly supports the use of leronlimab, as inflammation has persistent consequences.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼